---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-029778"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2025-12-31T23:59:59+00:00"
generated_at: "2026-05-16T11:53:17.336248+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lixte exchanges 2,700 Series C preferred for 700K common shares and 20% of Liora subsidiary

## Summary
- Orbit Capital Inc. exchanged 2,700 Series C Preferred shares for 700,000 Lixte common shares and 200 ordinary shares of Liora (20% of Liora).
- Upon closing, all Series C Preferred shares were cancelled and no longer outstanding.
- Lixte retained 800 ordinary shares of Liora after the exchange.
- Transaction was exempt from registration under Section 4(a)(2) and Regulation D.

## SEC filing metadata
- accession: 0001493152-25-029778
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2025-12-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315225029778/0001493152-25-029778-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315225029778/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-029778
- JSON: https://secwatch.observer/filing/0001493152-25-029778.json
- Plain text: https://secwatch.observer/filing/0001493152-25-029778.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.